Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6662)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2014 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chrostek L, Panasiuk A. Liver fibrosis markers in alcoholic liver disease. World J Gastroenterol 2014; 20(25): 8018-8023 [PMID: 25009372 DOI: 10.3748/wjg.v20.i25.8018] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i25/8018.htm |
| Number | Citing Articles |
| 1 |
Paul Carrier, Murielle Girard, Marilyne Debette-Gratien, Natacha Ouedraogo, Véronique Loustaud-Ratti, Philippe Nubukpo. Liver elastometry and alcohol withdrawal: Median-term follow-up in a psychiatric unit. Alcohol 2020; 89: 49 doi: 10.1016/j.alcohol.2020.07.007
|
| 2 |
Vladimir Vračarić, Božidar Dejanović, Nebojsa Janjić, Milica Zirojević, Željka Savić, Olgica Latinović Bosnjak, Tihomir Orlić, Žarko Krnetić, Dimitrije Damjanov, Maria Pete, Maja Ružić. Non-invasive Assessment of Liver Damage Degree in Patients with Viral Hepatitis: Is It Feasible and Acceptable?. Hepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-144504
|
| 3 |
Chengxia Xie, Bo Ma, Ning Wang, Lin Wan. Comparison of serological assessments in the diagnosis of liver fibrosis in bile duct ligation mice. Experimental Biology and Medicine 2017; 242(14): 1398 doi: 10.1177/1535370217718179
|
| 4 |
Xiaofeng Liu, Shuzhen Yu, Yao Zhang, Wei Zhang, Hao Zhong, Xiaoqin Lu, Rongfa Guan. A review on the protective effect of active components in Antrodia camphorata against alcoholic liver injury. Journal of Ethnopharmacology 2023; 300: 115740 doi: 10.1016/j.jep.2022.115740
|
| 5 |
Juan P. Arab, Juan P. Roblero, Jose Altamirano, Fernando Bessone, Roberta Chaves Araujo, Fatima Higuera-De la Tijera, Juan Carlos Restrepo, Aldo Torre, Alvaro Urzua, Douglas A. Simonetto, Juan G. Abraldes, Nahum Méndez-Sánchez, Fernando Contreras, Michael R. Lucey, Vijay H. Shah, Helena Cortez-Pinto, Ramon Bataller. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Annals of Hepatology 2019; 18(3): 518 doi: 10.1016/j.aohep.2019.04.005
|
| 6 |
Novriantika Lestari, Melva Louisa, Vivian Soetikno, Averina Geffanie Suwana, Putra Andito Ramadhan, Taufiq Akmal, Wawaimuli Arozal. Alpha Mangostin Inhibits the Proliferation and Activation of Acetaldehyde Induced Hepatic Stellate Cells through TGF-β and ERK 1/2 Pathways. Journal of Toxicology 2018; 2018: 1 doi: 10.1155/2018/5360496
|
| 7 |
Lucas Trevisan França de Lima, Darrell H.G. Crawford, Daniel A. Broszczak, Xi Zhang, Kim Bridle R., Chamindie Punyadeera. A salivary biomarker panel to detect liver cirrhosis. iScience 2023; 26(7): 107015 doi: 10.1016/j.isci.2023.107015
|
| 8 |
Qi Wang, Xuefei Dai, Wanzhi Yang, He Wang, Han Zhao, Feng Yang, Yan Yang, Jun Li, Xiongwen Lv. Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP/PKA/CREB pathway in rat hepatic stellate cells. International Immunopharmacology 2015; 25(2): 340 doi: 10.1016/j.intimp.2015.02.012
|
| 9 |
Chun-Yi Wang, Hsiang-Han Kao, Kuan-Yu Lai, Ching-Chun Lin, Wen-Yuan Lin, Chiu-Shong Liu, Tsung-Po Chen. Clinical and Metabolic Characteristics of Hyperuricemia with Risk of Liver Fibrosis: A Cross-Sectional Study. Metabolites 2022; 12(10): 893 doi: 10.3390/metabo12100893
|
| 10 |
A. F. Sheptulina, Ye. N. Shirokova, V. T. Ivashkin. Noninvasive diagnostic methods of liver fibrosis in patients with primary biliary cirrhosis and primary sclerosing cholangitis: role of indirect serological markers. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2016; 26(3): 52 doi: 10.22416/1382-4376-2016-26-3-52-63
|
| 11 |
Meritxell Ventura‐Cots, Nambi Ndugga, Ramon Bataller. Evidence‐based Gastroenterology and Hepatology 4e. 2019; : 503 doi: 10.1002/9781119211419.ch34
|
| 12 |
Yongli Zhou, Yandong Li, Na Wang, Xiuying Li, Jianyun Zheng, Liqiao Ge. UPF1 inhibits the hepatocellular carcinoma progression by targeting long non-coding RNA UCA1. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43148-z
|
| 13 |
Mack C. Mitchell, Gyongyi Szabo. Schiff's Diseases of the Liver. 2017; : 699 doi: 10.1002/9781119251316.ch26
|
| 14 |
Kazuya Kariyama, Kazuhiro Nouso, Hidenori Toyoda, Toshifumi Tada, Atsushi Hiraoka, Kunihiko Tsuji, Ei Itobayashi, Toru Ishikawa, Akiko Wakuta, Ayano Oonishi, Takashi Kumada, Masatoshi Kudo. Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma. Cancers 2019; 11(2): 203 doi: 10.3390/cancers11020203
|
| 15 |
Q. W. Song, Y. P. Yuan, Q. S. Sun, X. D. Zhan, Y. X. Jiang, X. N. Tang. Effects of Bulleyaconitine A on Extracellular Matrix Secretion and Expression of Related Proteins in Acetaldehyde-Activated Hepatic Stellate Cells. Bulletin of Experimental Biology and Medicine 2024; 177(1): 74 doi: 10.1007/s10517-024-06134-8
|
| 16 |
Cecilia Zertuche-Martínez, Juan Manuel Velázquez-Enríquez, Karina González-García, Rafael Baltiérrez-Hoyos, Gabriela Carrasco-Torres, Rebeca García-Román, Roberto Iván Romero-Díaz, José Luis Pérez-Hernández, Pablo Muriel, Saúl Villa-Treviño, Jaime Arellanes-Robledo, Verónica Rocío Vásquez-Garzón. Identification of ABCC3 and its isoforms as potential biomarker in hepatocellular carcinoma. Toxicology Mechanisms and Methods 2024; 34(4): 398 doi: 10.1080/15376516.2023.2294475
|
| 17 |
Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, Zebao He, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu. A novel non‐invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of Viral Hepatitis 2023; 30(4): 287 doi: 10.1111/jvh.13808
|
| 18 |
Freya A Rhodes, Paul Trembling, Jasmina Panovska‐Griffiths, Sudeep Tanwar, Rachel H Westbrook, Alison Rodger, William M Rosenberg. Systematic review: Investigating the prognostic performance of four non‐invasive tests in alcohol‐related liver disease. Journal of Gastroenterology and Hepatology 2021; 36(6): 1435 doi: 10.1111/jgh.15335
|
| 19 |
Viola Schlossberger, Mathias Worni, Christina Kihm, Matteo Montani, Christian Datz, Jochen Hampe, Felix Stickel. Plasma Levels of K18 Fragments Do Not Correlate with Alcoholic Liver Fibrosis. Gut and Liver 2019; 13(1): 77 doi: 10.5009/gnl18037
|
| 20 |
|
| 21 |
Hiroki Nishikawa, Yukio Osaki, Ekihiro Seki. Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/872152
|
| 22 |
Philippe Mathurin, Ramon Bataller. Trends in the management and burden of alcoholic liver disease. Journal of Hepatology 2015; 62(1): S38 doi: 10.1016/j.jhep.2015.03.006
|
| 23 |
Rosa Lombardi, Elena Buzzetti, Davide Roccarina, Emmanuel A Tsochatzis. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. World Journal of Gastroenterology 2015; 21(39): 11044-11052 doi: 10.3748/wjg.v21.i39.11044
|
| 24 |
Fengqin Wang, Ying Zhan, Manman Li, Lidan Wang, Austin Zheng, Changbai Liu, Hu Wang, Tao Wang. Cell-Permeable PROTAC Degraders against KEAP1 Efficiently Suppress Hepatic Stellate Cell Activation through the Antioxidant and Anti-Inflammatory Pathway. ACS Pharmacology & Translational Science 2023; 6(1): 76 doi: 10.1021/acsptsci.2c00165
|
| 25 |
Wendi Yu, Maosen Zeng, Peiping Xu, Jinyuan Liu, Huixian Wang. Effect of paeoniflorin on acute lung injury induced by influenza A virus in mice. Evidences of its mechanism of action. Phytomedicine 2021; 92: 153724 doi: 10.1016/j.phymed.2021.153724
|
| 26 |
Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe. Cirrhosis: Reviewing the Literature and Future Perspectives. EMJ Hepatology 2016; : 111 doi: 10.33590/emj/10310535
|
| 27 |
Jaime Arellanes-Robledo, Joseph Ibrahim, Karina Reyes-Gordillo, Ruchi Shah, Leslie Leckey, M. Raj Lakshman. Flightless-I is a potential biomarker for the early detection of alcoholic liver disease. Biochemical Pharmacology 2021; 183: 114323 doi: 10.1016/j.bcp.2020.114323
|
| 28 |
Arnaud Chalin, Bruno Turlin, Ahmad Ousmen, Sophie Michalak, Johannes Mueller, Sebastian Mueller, Ludivine Legros, Edouard Bardou‐Jacquet, Jean François Viel, Michel Samson, Romain Moirand. Non‐invasive diagnosis of alcohol‐related steatohepatitis in patients ongoing alcohol withdrawal based on cytokeratin 18 and transient elastography. Alimentary Pharmacology & Therapeutics 2023; 58(1): 80 doi: 10.1111/apt.17515
|
| 29 |
Koya Fujimoto, Takehiro Shiinoki, Yuki Yuasa, Hidekazu Tanaka. Estimation of liver elasticity using the finite element method and four‐dimensional computed tomography images as a biomarker of liver fibrosis. Medical Physics 2021; 48(3): 1286 doi: 10.1002/mp.14723
|
| 30 |
Gary L Norman, Nikolaos K Gatselis, Zakera Shums, Christos Liaskos, Dimitrios P Bogdanos, George K Koukoulis, George N Dalekos. Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(14): 1875-1883 doi: 10.4254/wjh.v7.i14.1875
|
| 31 |
Arantza Sanvisens, Alvaro Muñoz, Ferran Bolao, Paola Zuluaga, Magí Farré, Inmaculada Jarrin, Jordi Tor, Roberto Muga. Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?. Drug and Alcohol Dependence 2018; 188: 180 doi: 10.1016/j.drugalcdep.2018.04.008
|
| 32 |
Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, Ramón Bataller. Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection. Clinical and Molecular Hepatology 2023; 29(1): 1 doi: 10.3350/cmh.2022.0017
|
| 33 |
Subramaniam Arulvijayavani, Anbalagan Anithasri, Sivaneshan Harini. COMPARISON OF NON-INVASIVE FIBROSIS SCORES BETWEEN ALCOHOLIC LIVER DISEASE PATIENTS AND HEALTHY NON-ALCOHOLICS IN SOUTH INDIAN POPULATION. Journal of Evidence Based Medicine and Healthcare 2019; 6(31): 2084 doi: 10.18410/jebmh/2019/424
|
| 34 |
Tara Morgan, Aliya Qayyum, Richard M. Gore. Textbook of Gastrointestinal Radiology, 2-Volume Set. 2015; : 1629 doi: 10.1016/B978-1-4557-5117-4.00089-1
|
| 35 |
J Alfredo Martínez, Marta Alonso-Bernáldez, Diego Martínez-Urbistondo, Juan A Vargas-Nuñez, Ana Ramírez de Molina, Alberto Dávalos, Omar Ramos-Lopez. Machine learning insights concerning inflammatory and liver-related risk comorbidities in non-communicable and viral diseases. World Journal of Gastroenterology 2022; 28(44): 6230-6248 doi: 10.3748/wjg.v28.i44.6230
|
| 36 |
N. I. Geyvandova, G. K. Bolbat, A. V. Yagoda. Clinical significance of procollagen type III N-terminal peptide in patients with alcoholic liver disease. Medical alphabet 2024; (5): 32 doi: 10.33667/2078-5631-2024-5-32-35
|
| 37 |
Joo Hyun Oh, Sang Bong Ahn, Seon Cho, Eun-Hee Nah, Eileen L. Yoon, Dae Won Jun. Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort. Journal of Hepatology 2024; 81(5): 772 doi: 10.1016/j.jhep.2024.05.042
|
| 38 |
Jose Altamirano, Eric S. Orman, Ramon Bataller. Yamada' s Textbook of Gastroenterology. 2015; : 2043 doi: 10.1002/9781118512074.ch103
|
| 39 |
Liming Liu, Ying Zhou, Dan Dai, Hongmei Xia, Kang Zhao, Jianjun Zhang. Protective effects of Kangxian ruangan capsule against nonalcoholic fatty liver disease fibrosis in rats induced by MCD diet. Biomedicine & Pharmacotherapy 2018; 108: 424 doi: 10.1016/j.biopha.2018.06.134
|
| 40 |
Na Duan, Hongxia Chen, Liya Pi, Youssef Ali, Qi Cao. Cis-4-[18F]fluoro-L-proline PET/CT molecular imaging quantifying liver collagenogenesis: No existing fibrotic deposition in experimental advanced-stage alcoholic liver fibrosis. Frontiers in Nuclear Medicine 2022; 2 doi: 10.3389/fnume.2022.952943
|
| 41 |
Jian Wang, Xiaomin Yan, Li Zhu, Jiacheng Liu, Yuanwang Qiu, Yiguang Li, Yilin Liu, Ruifei Xue, Jie Zhan, Suling Jiang, Yu Geng, Yawen Wan, Ming Li, Minxin Mao, Dongmei Gao, Shengxia Yin, Xin Tong, Juan Xia, Weimao Ding, Yuxin Chen, Jie Li, Chuanwu Zhu, Rui Huang, Chao Wu. Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone. Alimentary Pharmacology & Therapeutics 2023; 57(5): 464 doi: 10.1111/apt.17272
|
| 42 |
HIROKI NISHIKAWA, YUKIO OSAKI, HIDEYUKI KOMEKADO, AZUSA SAKAMOTO, SUMIO SAITO, NORIHIRO NISHIJIMA, AKIHIRO NASU, AKIRA ARIMOTO, RYUICHI KITA, TORU KIMURA. Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection. Oncology Reports 2015; 33(1): 88 doi: 10.3892/or.2014.3573
|
| 43 |
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. Journal of Hepatology 2015; 63(1): 237 doi: 10.1016/j.jhep.2015.04.006
|
| 44 |
Maria Hernandez-Tejero, Ana Clemente-Sanchez, Ramon Bataller. Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease. Journal of Clinical and Experimental Hepatology 2023; 13(1): 75 doi: 10.1016/j.jceh.2022.10.002
|
| 45 |
Donogh Maguire, David P. Ross, Dinesh Talwar, Ewan Forrest, Hina Naz Abbasi, John‐Paul Leach, Marylynne Woods, Luke Y. Zhu, Scott Dickson, Tong Kwok, Isla Waterson, George Benson, Benjamin Scally, David Young, Donald C. McMillan. Low serum magnesium and 1‐year mortality in alcohol withdrawal syndrome. European Journal of Clinical Investigation 2019; 49(9) doi: 10.1111/eci.13152
|
| 46 |
Arunraj Namachivayam, Abilash Valsala Gopalakrishnan. A review on molecular mechanism of alcoholic liver disease. Life Sciences 2021; 274: 119328 doi: 10.1016/j.lfs.2021.119328
|
| 47 |
Novriantika Lestari, Daniel Amartya, Vivian Soetikno, Melva Louisa. Apoptotic activity of alpha-mangostin in acetaldehyde- induced LX2 hepatic stellate cell lines. THE 4TH BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, HEALTH, AND MEDICAL DEVICES: Proceedings of the International Symposium of Biomedical Engineering (ISBE) 2019 2019; 2193: 030019 doi: 10.1063/1.5139356
|
| 48 |
Z. Gordon Jiang, L. Feldbrügge, E. B. Tapper, Y. Popov, T. Ghaziani, N. Afdhal, S. C. Robson, K. J. Mukamal. Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. Alimentary Pharmacology & Therapeutics 2016; 43(6): 734 doi: 10.1111/apt.13515
|
| 49 |
Yu Huang, Xiangxue Fan, Ran Tao, Qiqin Song, Likui Wang, Hongyue Zhang, Hongyan Kong, Jiaquan Huang. Effect of miR‐182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway. Journal of Cellular Physiology 2018; 233(10): 6693 doi: 10.1002/jcp.26469
|
| 50 |
Jorge Soares, António Ferreira, André Silva-Pinto, Francisco Almeida, Carmela Piñeiro, Rosário Serrão, António Sarmento. The Influence of Antiretroviral Therapy on Hepatitis C Virus Viral Load and Liver Fibrosis in Human Immunodeficiency Virus-Coinfected Patients: An Observational Study. Intervirology 2019; 62(5-6): 182 doi: 10.1159/000503631
|
| 51 |
Zulfa Nooreen, Ankita Shukla, Anuja Shukla, Priyanka Verma. A Sustainable Approach Towards Prevention and Treatment of Hepatic
and Other Disorders Associated with Alcohol Consumption. Current Drug Therapy 2024; 19(5): 511 doi: 10.2174/1574885519666230915103206
|
| 52 |
Onni Niemelä. Advances In Clinical Chemistry. Advances in Clinical Chemistry 2023; 116: 113 doi: 10.1016/bs.acc.2023.05.002
|